Cargando…
Use of artificial intelligence to assess the risk of coronary artery disease without additional (non-invasive) testing: validation in a low-risk to intermediate-risk outpatient clinic cohort
OBJECTIVES: Predicting the presence or absence of coronary artery disease (CAD) is clinically important. Pretest probability (PTP) and CAD consortium clinical (CAD2) model and risk scores used in the guidelines are not sufficiently accurate as the only guidance for applying invasive testing or disch...
Autores principales: | Eurlings, Casper G M J, Bektas, Sema, Sanders-van Wijk, Sandra, Tsirkin, Andrew, Vasilchenko, Vasily, Meex, Steven J R, Failer, Michael, Oehri, Caroline, Ruff, Peter, Zellweger, Michael J, Brunner-La Rocca, Hans-Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516207/ https://www.ncbi.nlm.nih.gov/pubmed/36167368 http://dx.doi.org/10.1136/bmjopen-2021-055170 |
Ejemplares similares
-
Can artificial intelligence fill in the gaps in heart failure guidelines by providing precision medicine in medication advice?
por: Amin, H, et al.
Publicado: (2022) -
Biomarkers in outpatient heart failure management; Are they correlated to and do they influence clinical judgment?
por: Peeters, J. M. P. W. U., et al.
Publicado: (2013) -
Expedited Outpatient CTCA for Intermediate Risk Chest Pain During the COVID-19 Pandemic
por: Gray, R., et al.
Publicado: (2021) -
Natriuretic Peptides in Chronic Heart Failure
por: Brunner-La Rocca, Hans-Peter, et al.
Publicado: (2019) -
Improving kNowledge Transfer to Efficaciously RAise the level of Contemporary Treatment in Heart Failure (INTERACT-in-HF): Study protocol of a mixed methods study
por: Baldewijns, Karolien, et al.
Publicado: (2017)